Cemiplimab, a monoclonal IgG4 antibody, exhibits high affinity for the programmed death receptor-1 (PD-1). It effectively blocks the PD-1/PD-L1 interaction, which is critical in mediating T-cell suppression. This antibody is predominantly utilized in the study of squamous cell carcinoma of the skin, providing a valuable tool for investigating immune checkpoint blockade therapies in cancer research.
Cemiplimab, a monoclonal IgG4 antibody, exhibits high affinity for the programmed death receptor-1 (PD-1). It effectively blocks the PD-1/PD-L1 interaction, which is critical in mediating T-cell suppression. This antibody is predominantly utilized in the study of squamous cell carcinoma of the skin, providing a valuable tool for investigating immune checkpoint blockade therapies in cancer research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
